Pharmaco-economic study of FK 506 (Prograf) and cyclosporine A Neoral in cadaveric renal transplantation

Transplant Proc. 1998 Jun;30(4):1285-6. doi: 10.1016/s0041-1345(98)00243-7.

Authors

G Morris-Stiff¹, T Richards, J Singh, K Baboolal, V Balaji, K Ostrowski, R Moore, C Darby, R Lord, W A Jurewicz

Affiliation

¹ Department of Transplant Surgery, University of Wales Healthcare NHS Trust, Cardiff, Wales, United Kingdom.

PMID: 9636521
DOI: 10.1016/s0041-1345(98)00243-7

No abstract available

MeSH terms

Cadaver
Cost-Benefit Analysis
Cyclosporine / economics
Cyclosporine / therapeutic use*
Humans
Immunosuppressive Agents / economics
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / economics*
Kidney Transplantation / immunology*
Prospective Studies
Tacrolimus / economics
Tacrolimus / therapeutic use*
Tissue Donors
United Kingdom

Substances

Immunosuppressive Agents
Cyclosporine
Tacrolimus